Home > Insider Trading > Filing (0001104659-18-046330)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1658247	Crinetics Pharmaceuticals Inc.	CRNX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1219014	M Scott Rocklage	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1240357	D John Diekman	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1589314	5Am Partners Iv, Llc	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1589315	5Am Ventures Iv, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1593361	5Am Co-Investors Iv, L.p.	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No
1598549	J. Andrew Schwab	501 2Nd Street, Suite 350 San Francisco CA 94107	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-20	2,797,635	$0.00	2,797,635	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2018-07-20	451,274	$0.00	3,248,909	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2018-07-20	116,567	$0.00	116,567	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2018-07-20	18,802	$0.00	135,369	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2018-07-20	110,400	$17.00	3,359,309	No	4	P	Indirect	See footnotes
Common Stock	Acquisiton	2018-07-20	4,600	$17.00	139,969	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2018-07-20	9,204,220	$0.00	2,797,635	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-07-20	1,484,690	$0.00	451,274	$0.00
Common Stock	Series A Preferred Stock	Disposition	2018-07-20	383,507	$0.00	116,567	$0.00
Common Stock	Series B Preferred Stock	Disposition	2018-07-20	61,861	$0.00	18,802	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

These securities are held of record by 5AM Ventures IV, L.P. ("Ventures IV"). Following the transactions reported herein, 3,359,309 shares of Common Stock are held of record by Ventures IV.
These securities are held of record by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Following the transactions reported herein, 139,969 shares of Common Stock are held of record by Co-Investors IV.
5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV and Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV and Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
Each share of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common stock on a 3.29-for-1 basis, for no additional consideration, upon the closing of the Issuer's initial public offering. The Series A Preferred Stock and the Series B Preferred Stock had no expiration date.